Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ultralife (ULBI) EBITDA (2016 - 2025)

Ultralife (ULBI) has 15 years of EBITDA data on record, last reported at -$1.5 million in Q3 2025.

  • For Q3 2025, EBITDA fell 236.39% year-over-year to -$1.5 million; the TTM value through Sep 2025 reached $1.7 million, down 82.7%, while the annual FY2024 figure was $6.0 million, 18.13% down from the prior year.
  • EBITDA reached -$1.5 million in Q3 2025 per ULBI's latest filing, down from $1.8 million in the prior quarter.
  • Across five years, EBITDA topped out at $3.4 million in Q4 2023 and bottomed at -$1.5 million in Q3 2025.
  • Average EBITDA over 4 years is $1.4 million, with a median of $1.1 million recorded in 2021.
  • Peak YoY movement for EBITDA: soared 1884.56% in 2024, then crashed 236.39% in 2025.
  • A 4-year view of EBITDA shows it stood at $1.1 million in 2021, then surged by 216.73% to $3.4 million in 2023, then plummeted by 121.48% to -$728000.0 in 2024, then tumbled by 100.27% to -$1.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$1.5 million in Q3 2025, $1.8 million in Q2 2025, and $2.2 million in Q1 2025.